Trials / Conditions / Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
6 registered clinical trials studyying Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma NCT07388563 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Tazemetostat Plus CHOP in 1L T-cell Lymphoma NCT06692452 | Eric Jacobsen, MD | Phase 2 |
| Active Not Recruiting | Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T- NCT05377827 | Washington University School of Medicine | Phase 1 |
| Recruiting | A Registry for People With T-cell Lymphoma NCT05978141 | Memorial Sloan Kettering Cancer Center | — |
| Recruiting | A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas NCT05475925 | Dren Bio | Phase 1 / Phase 2 |
| Suspended | Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma NCT04803201 | Alliance for Clinical Trials in Oncology | Phase 2 |